Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Total Assets : ¥17,128 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co Total Assets?

Shijiazhuang Yiling Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 was ¥17,128 Mil.

During the past 12 months, Shijiazhuang Yiling Pharmaceutical Co's average Total Assets Growth Rate was 0.10% per year. During the past 3 years, the average Total Assets Growth Rate was 16.70% per year. During the past 5 years, the average Total Assets Growth Rate was 18.20% per year. During the past 10 years, the average Total Assets Growth Rate was 14.60% per year.

During the past 13 years, Shijiazhuang Yiling Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 47.50%. The lowest was 10.30%. And the median was 18.80%.

Total Assets is connected with ROA %. Shijiazhuang Yiling Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 was 7.13%. Total Assets is also linked to Revenue through Asset Turnover. Shijiazhuang Yiling Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.15.

Shijiazhuang Yiling Pharmaceutical Co Total Assets Historical Data

The historical data trend for Shijiazhuang Yiling Pharmaceutical Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shijiazhuang Yiling Pharmaceutical Co Total Assets Chart

Shijiazhuang Yiling Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

9,069.40

11,508.19

12,904.84

16,340.66

16,979.33

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															18,246.70	18,153.60	17,435.00	16,979.33	17,128.47

Shijiazhuang Yiling Pharmaceutical Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Shijiazhuang Yiling Pharmaceutical Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	11437.995	+	5541.331
	=	16,979

Shijiazhuang Yiling Pharmaceutical Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	11739.882	+	5388.589
	=	17,128

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Total Assets Explanation

Total Assets is connected with ROA %.

Shijiazhuang Yiling Pharmaceutical Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	1215.712	/	( (16979.327	+	17128.471)	/ 2 )
	=	1215.712	/	17053.899
	=	7.13 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Shijiazhuang Yiling Pharmaceutical Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	2522.633	/	( (16979.327	+	17128.471)	/ 2 )
=	2522.633	/	17053.899
=	0.15

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Shijiazhuang Yiling Pharmaceutical Co Total Assets Related Terms

Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » Total Assets

Traded in Other Exchanges

N/A

Address

No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN

Website

http://www.yiling.cn/

Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.

Executives

Zhang Qiu Lian	Directors, executives
Han Yue Zhi	Executives
Zhao Shao Hua	Executives
Wang Wei	Executives
Gao Xue Dong	Supervisors
Wu Yi Ling	Director
Gao Xiu Qiang	Executives
Wu Xiang Jun	Directors, executives
Guo Shuang Geng	Director
Wang Hua	Securities Affairs Representative
Dai Feng Xiang	Directors, executives
Liu Gen Wu	Supervisors
Wang Wei Ping	Directors, executives
Xu Wei Dong	Director
Wu Rui	Directors, executives

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines